These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7015276)
1. [Scleroderma complicated by arterial hypertension and kidney failure: treatment with captopril]. Flechet ML; Bravard P; Godin M Nouv Presse Med; 1981 May; 10(22):1848. PubMed ID: 7015276 [No Abstract] [Full Text] [Related]
2. [Scleroderma complicated by arterial hypertension and renal insufficiency. Favorable effects of captopril]. Grünfeld JP; Pulik M; Reveillaud RJ; Martinet C Nouv Presse Med; 1980 Oct; 9(36):2658. PubMed ID: 7001352 [No Abstract] [Full Text] [Related]
3. [Beneficial effect of the converting enzyme inhibitor on the acute renal failure of scleroderma with arterial hypertension]. Mercatello A; Zech PY Nouv Presse Med; 1981 Apr; 10(19):1596. PubMed ID: 7025853 [No Abstract] [Full Text] [Related]
4. [Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance]. Bonnet F; Matamis D; Lepresle E; Cabane J; Le Gall JR Nouv Presse Med; 1982 May; 11(20):1570-1. PubMed ID: 7048249 [No Abstract] [Full Text] [Related]
5. [Treatment of arterial hypertension with captopril]. Fillastre JP; Godin M; Josse S; Borsa F; Bercoff E Nouv Presse Med; 1980 Sep; 9(35):2575-6. PubMed ID: 7001350 [No Abstract] [Full Text] [Related]
6. Captopril in the treatment of scleroderma renal crisis. Thurm RH; Alexander JC Arch Intern Med; 1984 Apr; 144(4):733-5. PubMed ID: 6370160 [TBL] [Abstract][Full Text] [Related]
7. [Results of captopril therapy of arterial hypertension in children with terminal renal failure]. Gura C; Sieniawska M; Welc-Dobies J Pediatr Pol; 1985 Feb; 60(2):177-85. PubMed ID: 3895149 [No Abstract] [Full Text] [Related]
8. [Administration of angiotensin I converting enzyme inhibitor captopril, in a case of renal crisis of scleroderma--the effects of captopril to the temperature of the skin lesion in scleroderma (author's transl)]. Gotoh S; Ogihara T; Hata T; Maruyama A; Naka T; Nakamaru M; Mikami H; Masuo K; Kumahara Y Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1133-41. PubMed ID: 7033607 [No Abstract] [Full Text] [Related]
9. Failure of captopril to reverse the renal crisis of scleroderma. Brown EA; Macgregor GA; Maini RN Ann Rheum Dis; 1983 Feb; 42(1):52-3. PubMed ID: 6338841 [TBL] [Abstract][Full Text] [Related]
10. Long term effect of captopril in hypertension with chronic renal failure. Gassia JP; Durand D; Ton That H; Degroc F; Suc JM Proc Eur Dial Transplant Assoc; 1980; 17():719-24. PubMed ID: 7017704 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of renal crisis in progressive systemic sclerosis with captopril]. Latorre LC; Mion D; Zerbini CA; Pastor EH; Resende C; Fidelis TS; Gabriel Júnior A; Assad RL; Cossermelli W Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):18-21. PubMed ID: 3903950 [No Abstract] [Full Text] [Related]
12. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)]. El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of resistant hypertension with captopril in children with terminal insufficiency of renal function]. Peco-Antić A; Popović-Rolović M; Popović D; Calić-Perisić N; Mancić J Srp Arh Celok Lek; 1983 Mar; 111(3):341-54. PubMed ID: 6362034 [No Abstract] [Full Text] [Related]
16. [Value of captopril in the treatment of systemic arterial and pulmonary hypertension with increased plasma renin in scleroderma]. Richard C; Ricome JL; Lemoine F; Rimailho A; Lantz O; Auzépy P Rev Med Interne; 1983 Jun; 4(2):125-9. PubMed ID: 6351212 [TBL] [Abstract][Full Text] [Related]
17. [Value of captopril in systemic lupus erythematosus with arterial hypertension and renal insufficiency]. Cervera R; Font J; Ingelmo M Med Clin (Barc); 1987 Jun; 89(3):129-30. PubMed ID: 3306188 [No Abstract] [Full Text] [Related]
18. [Captopril in the treatment of arterial hypertension. Studies of the therapeutic effectiveness and the alleged nephrotoxicity of the drug]. Bellini G; Faccini L; Battilana G; Carretta R; Rigoni A; Puppis E; Rustia R; Englaro E; Carraro M; Fabris B; Menchini U G Clin Med; 1981 Nov; 62(11):789-800. PubMed ID: 7040155 [No Abstract] [Full Text] [Related]
19. Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril. Waeber B; Schaller MD; Wauters JP; Brunner HR Klin Wochenschr; 1984 Aug; 62(15):728-30. PubMed ID: 6387262 [TBL] [Abstract][Full Text] [Related]
20. Clinical course of patients with scleroderma renal crisis treated with captopril. Zawada ET; Clements PJ; Furst DA; Bloomer HA; Paulus HE; Maxwell MH Nephron; 1981; 27(2):74-8. PubMed ID: 7022235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]